Prices of Paracetamol surge by 40pc as coronavirus shuts China

Prices of paracetamol, the most commonly used analgesic, have jumped by 40% in India, while the cost of azithromycin, an antibiotic used for treating a variety of bacterial infections, has risen by 70%, said Pankaj R Patel, chairman of Zydus Cadila.

Published On 2020-02-18 07:51 GMT   |   Update On 2020-02-18 07:51 GMT

New Delhi:  India is facing the ripple effects of shutdowns in China with the production of medicines being hit as supply chain disruptions prolong.

Prices of paracetamol, the most commonly used analgesic, have jumped by 40% in India, while the cost of azithromycin, an antibiotic used for treating a variety of bacterial infections, has risen by 70%, said Pankaj R Patel, chairman of Zydus Cadila. The pharma industry could face shortages in finished drug formulations starting April if supplies aren't restored by the first week of next month, he said.

Also Read: CDSCO Declares 36 Samples Of Atorvastatin, Metformin, Paracetamol, Others As Not Of Standard Quality

The coronavirus, which has killed more than 1,000 people and stoked fears of a broader slowdown in China, has disrupted global supply lines after factories there slowed production and people were restricted from moving in and out of the country. As manufacturers based in China restart factories, nations such as India that depend heavily on imports of some raw material and intermediate goods from the mainland continue to face uncertainty.

Patel sees a substantial increase in prices of active pharmaceutical ingredients — the basic substance used to make drugs — in the short- to medium-term. India, one of the largest suppliers of generic drugs to the world and home to about 12% of all manufacturing sites catering to the US market, relies on China for as much as 80% of active pharmaceutical ingredient requirement.

Also Read: Granules India Gets EIR From USFDA For Paracetamol, Metformin API Manufacturing Plant 

Tags:    
Article Source : Bloomberg

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News